Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 28, Issue 7, 2013, Pages 1762-1772

  Kodama, Fumiko ^a   Asanuma, Katsuhiko ^a   Takagi, Miyuki ^a   Hidaka, Teruo ^a   Asanuma, Etsuko ^a   Fukuda, Hiromitsu ^a   Seki, Takuto ^a   Takeda, Yukihiko ^a   Hosoe Nagai, Yoshiko ^a   Asao, Rin ^a   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dendrin; Glomerulosclerosis; IgA nephropathy; Podocyte

Indexed keywords

CATHEPSIN L; CELL PROTEIN; DENDRIN; LIPOCORTIN 5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MALE; NEPHROTIC SYNDROME; PODOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; URINALYSIS;

DENDRIN; GLOMERULOSCLEROSIS; IGA NEPHROPATHY; PODOCYTE;

ACUTE KIDNEY INJURY; ADULT; APOPTOSIS; BIOLOGICAL MARKERS; CELL NUCLEUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY GLOMERULUS; MALE; NERVE TISSUE PROTEINS; PODOCYTES; PROTEIN TRANSPORT; YOUNG ADULT;

EID: 84884518668     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs500     Document Type: Article

References (48)

1. Rychlik I, Andrassy K, Waldherr R et al. Clinical features and natural history of IgA nephropathy. Ann Med Interne (Paris) 1999; 150: 117-126
2. Lemely KV, Lafayette RA, Safari M et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002; 61: 1475-1485
3. Wharram BL, Goyal M, Wiggins JE et al. Podocyte depletion glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16: 2941-2952
4. Matsusaka T, Xin J, Niwa S et al. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 2005; 16: 1012-1023
5. Kim YH, Goyal M, Kurnit D et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001; 60: 957-968
6. Pagtalunan ME, Miller PL, Jumping-Eagle S et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99: 342-348
7. Hishiki T, Shirato I, Takahashi Y et al. Podocyte injury predicts prognosis in patients with IgA nephropathy using a small amount of renal biopsy tissue. Kidney Blood Press Res 2000; 24: 99-104
8. Hara M, Yamamoto T, Yanagihara T et al. Urinary excretion of podocaryxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron 1995; 69: 397-403
9. Hara M, Yanagihara T, Kihara I. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schonlein-Henoch purpura nephritis. Clin J Am Soc Nephrol 2007; 2: 231-238
10. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13: 3005-3015
11. Vogelmann SU, Nelson WJ, Myers BD et al. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003; 285: F40-F48
12. Hara M, Yanagihara T, Takada T et al. Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 1998; 18: 35-41
13. Hara M, Yanagihara T, Kihara I. Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 2001; 89: 342-347
14. Nakamura T, Ushiyama C, Suzuki S et al. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 2000; 15: 1379-1383
15. Hara M, Yanagihara T, Kihara I et al. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. J Am Soc Nephrol 2005; 16: 408-416
16. Yu D, Petermann A, Kunter U et al. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005; 16: 1733-1741
17. Habara P, Mareckova H, Sopkova Z et al. A novel method for the estimation of podocyte injury: podocalyxin-positive elements in urine. Folia Biologica 2008; 54: 162-167
18. Niranjan T, Bielesz B, Gruenwald A et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008; 14: 290-298
19. Lee HS, Song CY. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies. Kidney Blood Press Res 2010; 33: 24-29
20. Schiffer M, Bitzer M, Roberts IS et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001; 108: 807-816
21. Zhang C, Hu JJ, Xia M et al. Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes. Biochim Biophys Acta 2009; 1803: 482-491
22. Yi F, dos Santos EA, Xia M et al. Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats. Am J Nephrol 2007; 27: 262-268
23. Asanuma K, Campbell KC, Kim K et al. Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes. PNAS 2007; 104. 24: 10134-10139
24. Patrakka J, Xiao Z, Nukui M et al. Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066E14Rik. J Am Soc Nephrol 2007; 18: 689-697
25. Duner F, Patrakka J, Xiao Z et al. Dendrin expression in glomerulogenesis and in human minimal change nephrotic syndrome. Nephrol Dial Transplant 2008; 23: 2504-2511
26. Sciffer M, Mundel P, Shaw AS et al. A novel role for the adaptor molecule CD-associated protein in transforming growth factorbeta-induced apoptosis. J Biol Chem 2004; 279: 37004-37012
27. Yaddanapudi S, Altintas MM, Kistler AD et al. CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. JCI 2011; 121: 3965-3980
28. Asanuma K, Takagi-Akiba M, Kodama F et al. Dendrin location in podocytes is associated with the disease progression in animal and human glomerulopathy. Am J Nephrol 2011; 33: 537-549
29. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 932-935
30. Sakai H, Abe K, Kobayashi Y et al. Clinical guidelines of IgA nephropathy. Jpn J Nephrol 1995; 37: 417-421
31. Tomino Y, Sakai H. Special study group (IgA nephropathy) on progressive glomerular disease: clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 2003; 7: 93-97
32. Shigematsu H. Histological grading and staging of IgA nephropathy. Pathol Int 1997; 47: 194-202
33. Cattran DC, Coppo R, Cook HT et al. A Working Group of the International IgA Nephropathy Network and the Renal Biopsy Society: the Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545
34. Roberts IS, Cook HT, Troyanov S et al. A Working Group of the International IgA Nephropathy Network and the Renal Biopsy Society: the Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009; 76: 546-556
35. Mundel P, Heid HW, Mundel TM et al. Synaptopodin: an actinassociated protein in telencephalic dendrites and renal podocytes. J Cell Biol 1997; 139: 193-204
36. Hill GS, Karoui KE, Karras A et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy: immunohistochemical studies. Kidney Int 2011; 79: 635-642
37. El Karoui K, Hill GS, Karras A et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int 2011; 79: 643-654
38. Cybulsky AV, Takano T, Papillon J et al. Glomerular epithelial cell injury associated with mutant alfa-actinin-4. Am J Physiol Renal Physiol 2009; 297: F987-F995
39. Lee SH, Yoo TH, Nam BY et al. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions. Am J Physiol Renal Physiol 2009; 297: F1381-F1390
40. Mariano F, Cantaluppi V, Stella M et al. Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 2008; 12: R42
41. Cantaluppi V, Assenzio B, Pasero D et al. Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 2008; 34: 1638-1645
42. Engeland M, Nieland L, Ramaekers F et al. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31: 1-9
43. Kuge Y, Zhao S, Takei T et al. Molecular imaging of apoptosis with radio-labeled Annexin A5 focused on the evaluation of tumor response to chemotherapy. Anticancer Agents Med Chem 2009; 9: 1003-1011
44. Reiser J, Oh J, Shirato I et al. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem 2004; 279: 34827-34832
45. Sever S, Altintas MM, Nankoe SR et al. Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest 2007; 117: 2095-2104
46. Mundlos S, Pelletier J, Darveau A et al. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 1993; 119: 1329-1341
47. Sanden SK, Wiggins JE, Goyal M et al. Evaluation of thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker. J Am Soc Nephrol 2003; 14: 2484-2493
48. Murea M, Park J-K, Sharma S et al. Expression of Notch pathway proteins correlates with alubuminuria, glomerulosclerosis, and renal function. Kidney Int 2010; 78: 514-522